215 related articles for article (PubMed ID: 28644424)
1. The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis.
Liu D; Peng H; Sun Q; Zhao Z; Yu X; Ge S; Wang H; Fang H; Gao Q; Liu J; Wu L; Song M; Wang Y
Int J Environ Res Public Health; 2017 Jun; 14(7):. PubMed ID: 28644424
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of genes in sputum samples as diagnostic biomarkers for non-small cell lung cancer: a meta-analysis.
Wang X; Ling L; Su H; Cheng J; Jin L
Asian Pac J Cancer Prev; 2014; 15(11):4467-74. PubMed ID: 24969871
[TBL] [Abstract][Full Text] [Related]
3. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
[No Abstract] [Full Text] [Related]
4. Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection.
Su Y; Fang H; Jiang F
Clin Epigenetics; 2016; 8():109. PubMed ID: 27777637
[TBL] [Abstract][Full Text] [Related]
5. P16
Tuo L; Sha S; Huayu Z; Du K
Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
[TBL] [Abstract][Full Text] [Related]
6. Correlation Between RASSF1A Gene Promoter Hypermethylation in Serum or Sputum and Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
Zhang Z; Yan S; Cui H; Chen H; Liu J
Med Sci Monit; 2019 Jul; 25():5518-5524. PubMed ID: 31342946
[TBL] [Abstract][Full Text] [Related]
7. DNA hypermethylation analysis in sputum of asymptomatic subjects at risk for lung cancer participating in the NELSON trial: argument for maximum screening interval of 2 years.
Hubers AJ; Heideman DA; Duin S; Witte BI; de Koning HJ; Groen HJ; Prinsen CF; Bolijn AS; Wouters M; van der Meer SE; Steenbergen RD; Snijders PJ; Uyterlinde A; Berkhof H; Smit EF; Thunnissen E
J Clin Pathol; 2017 Mar; 70(3):250-254. PubMed ID: 27496969
[TBL] [Abstract][Full Text] [Related]
8. APC gene promoter methylation as a potential biomarker for lung cancer diagnosis: A meta-analysis.
Liu F; Lu X; Zhou X; Huang H
Thorac Cancer; 2021 Nov; 12(21):2907-2913. PubMed ID: 34545707
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers.
Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE
Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099
[TBL] [Abstract][Full Text] [Related]
10. An epigenetic classifier for early stage lung cancer.
Su Y; Fang HB; Jiang F
Clin Epigenetics; 2018; 10():68. PubMed ID: 29796119
[TBL] [Abstract][Full Text] [Related]
11. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: a nested case-control study.
Cirincione R; Lintas C; Conte D; Mariani L; Roz L; Vignola AM; Pastorino U; Sozzi G
Int J Cancer; 2006 Mar; 118(5):1248-53. PubMed ID: 16152615
[TBL] [Abstract][Full Text] [Related]
12. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis.
Hubers AJ; Brinkman P; Boksem RJ; Rhodius RJ; Witte BI; Zwinderman AH; Heideman DA; Duin S; Koning R; Steenbergen RD; Snijders PJ; Smit EF; Sterk PJ; Thunnissen E
J Clin Pathol; 2014 Aug; 67(8):707-11. PubMed ID: 24915850
[TBL] [Abstract][Full Text] [Related]
13. DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach.
Hubers AJ; Heideman DA; Burgers SA; Herder GJ; Sterk PJ; Rhodius RJ; Smit HJ; Krouwels F; Welling A; Witte BI; Duin S; Koning R; Comans EF; Steenbergen RD; Postmus PE; Meijer GA; Snijders PJ; Smit EF; Thunnissen E
Br J Cancer; 2015 Mar; 112(6):1105-13. PubMed ID: 25719833
[TBL] [Abstract][Full Text] [Related]
14. Methylated Cell-Free Tumor DNA in Sputum as a Tool for Diagnosing Lung Cancer-A Systematic Review and Meta-Analysis.
Wen SWC; Borg M; Timm S; Hansen TF; Hilberg O; Andersen RF
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339257
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
16. Methylation analysis in spontaneous sputum for lung cancer diagnosis.
Hubers AJ; van der Drift MA; Prinsen CF; Witte BI; Wang Y; Shivapurkar N; Stastny V; Bolijn AS; Hol BE; Feng Z; Dekhuijzen PN; Gazdar AF; Thunnissen E
Lung Cancer; 2014 May; 84(2):127-33. PubMed ID: 24598366
[TBL] [Abstract][Full Text] [Related]
17. Gene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood.
Wang BH; Li YY; Han JZ; Zhou LY; Lv YQ; Zhang HL; Zhao L
Oncotarget; 2017 May; 8(19):31692-31704. PubMed ID: 28404957
[TBL] [Abstract][Full Text] [Related]
18. Variability in the measurement of the methylation status of lung cancer-related genes in bronchial secretions.
Millares L; Rosell A; Setó L; Sanz J; Andreo F; Monsó E
Oncol Rep; 2014 Oct; 32(4):1435-40. PubMed ID: 25069886
[TBL] [Abstract][Full Text] [Related]
19. Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non-Small Cell Lung Cancer.
Liu B; Ricarte Filho J; Mallisetty A; Villani C; Kottorou A; Rodgers K; Chen C; Ito T; Holmes K; Gastala N; Valyi-Nagy K; David O; Gaba RC; Ascoli C; Pasquinelli M; Feldman LE; Massad MG; Wang TH; Jusue-Torres I; Benedetti E; Winn RA; Brock MV; Herman JG; Hulbert A
Clin Cancer Res; 2020 Aug; 26(16):4339-4348. PubMed ID: 32430478
[TBL] [Abstract][Full Text] [Related]
20. Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer.
Li N; Zeng Y; Huang J
J Cancer Res Clin Oncol; 2020 Jun; 146(6):1379-1393. PubMed ID: 32266538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]